Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Asthma × Formoterol Fumarate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Asthma 1

Interventions

Fluticasone-Salmeterol Drug Combination 3 Etanercept 3 Fluticasone 2 Budesonide 2 Beclomethasone 2 perflutren 1 laninamivir 1 fluticasone-formoterol 1 Surveys and Questionnaires 1 Sulfur Hexafluoride 1 Spirometry 1 Prednisolone 1 NVP-QAV680 1 Lysine Acetyltransferase 5 1 Helium 1 Health Information Exchange 1 Fractional Exhaled Nitric Oxide Testing 1 Formoterol Fumarate 1 Escitalopram 1 Electrocardiography 1 Drug Delivery Systems 1 CS 8958 1 Budesonide, Formoterol Fumarate Drug Combination 1 Bronchial Thermoplasty 1 Blood Specimen Collection 1 Azithromycin 1 Amoxicillin-Potassium Clavulanate Combination 1 Albuterol 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00646516 2011-01-24

Gemini Symbicort pMDI

AstraZeneca

Phase 3 Completed

Asthma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡